[Treatment of neuroleptic-induced tremor with the beta-blocker bupranolol (author's transl)].
D014150:Antipsychotic Agents / Q000009:adverse effects*; D001712:Biperiden / Q000627:therapeutic use; D002046:Bupranolol / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007700:Kinetics; D008297:Male; D011412:Propanolamines / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D013997:Time Factors; D014202:Tremor / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology
D014150:Antipsychotic Agents; D011412:Propanolamines; D001712:Biperiden; D002046:Bupranolol
Die Behandlung des neuroleptikabedingten Tremors mit dem beta-blocker bupranolol.